If you have a condition affecting the back of your eye, knowing how blood flows there matters. A new imaging tool called Laser Doppler Holography (LDH) can measure that flow quickly and without needles. Researchers pooled data from a small set of studies to get a baseline picture of the choroidal arteries, the tiny vessels that nourish the retina. They found a pooled mean diameter of 134.2 micrometers, with a range of 128.3 to 140.1 micrometers. This gives clinicians a reference point when using LDH to study people with choroidal blood flow issues. The review included only eight studies for a qualitative look and just two for the pooled measurement, so the picture is still early and limited. No safety problems were reported, but the studies didn’t track adverse events. LDH is promising because it’s non-invasive and fast, but we need more research to know how it performs across different patients and conditions.
Systematic review of Laser Doppler Holography for choroidal blood flow assessmentNew imaging tool maps eye blood flow quickly and safely
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Consider the limited evidence on LDH for choroidal blood flow, noting only 2 studies in the meta-analysis.
This is a systematic review with meta-analysis of Laser Doppler Holography (LDH) for assessing choroidal blood flow in humans. The scope was to synthesize evidence on choroidal artery diameter and hemodynamic parameters from studies using LDH.
The authors identified only 8 studies for qualitative synthesis, with only 2 studies included in the meta-analysis. The pooled mean diameter of choroidal arteries was 134.2 μm (95% CI: 128.3 to 140.1 μm). Other outcomes assessed included hemodynamic parameters and vascular anatomy.
Key limitations acknowledged by the authors are the very small number of studies meeting inclusion criteria, with only 2 studies contributing to the pooled analysis. This severely limits the generalizability and robustness of the findings.
The authors conclude that LDH is a promising and versatile technique for studying choroidal blood flow quickly and non-invasively. However, the evidence base is preliminary, and practice relevance is constrained by the limited data. Clinicians should interpret these findings cautiously given the small number of studies.
What this means for you:
LDH offers a quick, non-invasive way to measure eye blood flow, but evidence is still early. View Original Abstract ↓
IntroductionQuantitative choroidal blood flow assessment is important for understanding chorioretinal diseases. Laser Doppler Holography (LDH) is a new non-invasive imaging technique that provides full-field, high-temporal-resolution assessments of ocular hemodynamics. This systematic review synthesizes evidence on LDH’s technical capabilities, clinical applications, and provides normative reference values for choroidal vascular anatomy.MethodsA systematic search of the literature was undertaken in accordance with PRISMA guidelines. Studies that evaluated choroidal blood flow in humans using LDH were identified. Data on technical specifications, hemodynamic parameters, and vascular anatomy were extracted for narrative synthesis.ResultsThe comprehensive literature search resulted in 347 records, with 8 studies that met the inclusion criteria for qualitative synthesis, as well as 2 studies that could be included in the meta-analysis. The pooled mean diameter of the choroidal arteries was derived to be 134.2 μm (95% CI: 128.3 to 140.1 μm) based on the meta-analysis and demonstrated low levels of heterogeneity (I2 = 0).DiscussionThe narrative synthesis found that LDH could assess choroidal vasculature, differentiate arteries from veins using both flow waveforms and spectral data, deliver quantitative data for hemodynamic parameters, and assess blood flow directionality. LDH is a promising and versatile technique to study choroidal blood flow quickly and non-invasively.
Systematic review of extensive macular atrophy with pseudodrusen reports visual acuity decline and atrophy progression
Eye disease linked to vision loss and thicker eye layers in study
Related in Ophthalmology
FDA Approves Fluorescite (fluorescein sodium) for Retinal and Iris Angiography
FDA approves Fluorescite injection for eye imaging tests.
The FDA approved Fluorescite Injection 10% for diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature. The adul…
The FDA approved Fluorescite Injection 10% for use in eye imaging tests to examine blood flow in the retina and iris. It helps doctors detec…
Combined phacoemulsification and angle filtering reduce intraocular pressure and medication needs in glaucoma patients
Combined surgery lowers eye pressure better than cataract surgery alone
This meta-analysis of 14 randomized controlled trials evaluated combined phacoemulsification and angle filtering compared to phacoemulsifica…
For glaucoma patients with cataracts, combining two procedures in one surgery may better protect vision than cataract surgery alone.
Intravitreal ziv-aflibercept reduces central macular thickness and improves visual acuity in DME and RVO
Trial shows ziv-aflibercept improves vision in macular edema cases
This systematic review and meta-analysis of 5 RCTs and 8 observational studies found that intravitreal ziv-aflibercept significantly reduced…
A new eye treatment called ziv-aflibercept may help reduce swelling and improve vision for patients with specific types of macular edema.
Glaucoma drainage device implantation yields 65% success rate in uveitic glaucoma meta-analysis
Glaucoma Drainage Devices Show Promise for Uveitic Glaucoma
This systematic review and meta-analysis of 38 studies (1083 eyes) found an overall surgical success rate of 65.40% for glaucoma drainage de…
A review of 38 studies finds drainage devices help lower eye pressure in uveitic glaucoma, with different devices offering distinct benefits…
From Other Specialties
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …
Rapid advancements in imaging and blood-based biomarkers are transforming the diagnosis and management of ADRD
New guidelines help doctors tell delirium from dementia
This clinical guideline provides a narrative review on the evolving diagnostic and treatment landscape for Alzheimer's disease and related d…
Delirium is acute and fluctuating; dementia is chronic. New guidelines help doctors tell them apart.
ACTH and vigabatrin achieved full seizure control in a patient with Ververi-Brady syndrome
ACTH and Vigabatrin Show Promise for Rare Epilepsy Syndrome
This case report describes a 5-month-old male infant with Ververi-Brady syndrome and infantile epileptic spasms syndrome. The patient achiev…
A new gene variant linked to Ververi-Brady syndrome showed positive results when treated with a combination of ACTH and vigabatrin.